In accordance with Article 43 of Regulation (EC) No 396/2005, the Commission requested the Authority to assess the risks the current MRLs for acetamiprid may pose to consumers in the light of the resulting lower acute reference dose (ARfD).
Recital 8, Regulation (EU) 2019/88
In forcesince 18 Jan 2019